Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Glaxosmithkline Corporate Intellectual Property, Mai B475 patentsThe following is a sampling of recent Glaxosmithkline Corporate Intellectual Property, Mai B475 patent applications (USPTO Patent Application #, Patent Title) sorted by month.
August 2008 - Glaxosmithkline Corporate Intellectual Property, Mai B475 patents
20080207708 - Oxazole and thiazole compounds and their use in the treatment of pge2 mediated disorders
July 2008 - Glaxosmithkline Corporate Intellectual Property, Mai B475 patents
20080182831 - Androstane 17-alpha carbonate derivatives for use in the treatment of allergic and inflammatory conditions
20080176832 - Pyrazolo [3,4-d]azepine derivatives as histamine h3 antagonists
20080171740 - Chemical compounds
20080166298 - 6- (2, 3, 4, 5-tetrahydro-1h-benzo [d] azepin-7-yloxy) -nicotamide derivatives as radio labelled ligands
20080167356 - Farnesoid x receptor agonists
20080167360 - Cycloalkylidene compounds as selective estrogen receptor modulators
20080167377 - Novel compounds
20080161289 - Fused thiazole derivatives having affinity for the histamine h3 receptor
June 2008 - Glaxosmithkline Corporate Intellectual Property, Mai B475 patents
20080149098 - Fluid dispenser
20080153872 - Bis-(coumarin) compounds with anti-inflammatory activity
20080146563 - 1,7-naphthyridines as pde4 inhibitors
20080134489 - Device housing for an aerosol container
20080135043 - Inhalation devices
20080139594 - Imidazo-pyridine derivatives for use in the treatment of herpes viral infection
20080139631 - Chemical compounds
20080128970 - Object handling system and method
20080132505 - Combination of cb2 modulators and pde4 inhibitors for use in medicine
20080132526 - Purine derivative
May 2008 - Glaxosmithkline Corporate Intellectual Property, Mai B475 patents
20080125428 - Cancer treatment method
20080125462 - Cinnamate salts of a beta-2 adrenergic agonist
20080113926 - 9a-carbamoyl-y-aminopropyl- and 9a-thiocabamoyl-y-aminopropyl-azalides with antimalarial activity
20080113996 - Medicaments
20080105253 - Dispensing device
20080108624 - Methylene dipiperidine derivatives
20080098600 - Valve for aerosol container
20080103164 - Useful compounds for hpv infection
20080103186 - Novel crystalline forms of an antiviral benzimidazole compound
April 2008 - Glaxosmithkline Corporate Intellectual Property, Mai B475 patents
20080092881 - Inhalation devices
20080095788 - Vaccines
20080096239 - Orphan nuclear receptor
20080096830 - Anti-inflammatory macrolide conjugates
20080096861 - Chemical compounds
20080096884 - 4-aminoquinoline-3-carboxamide derivatives as pde4 inhibitors
20080096921 - Farnesoid x receptor agonists
March 2008 - Glaxosmithkline Corporate Intellectual Property, Mai B475 patents
20080069832 - Vaccines
20080070880 - Specific glucocorticosteroid compound having anti-inflammatory activity
20080060645 - Dry powder inhalant composition
20080058333 - Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors
20080058391 - Novel compounds
20080058515 - Chemical compounds
20080058519 - Quinazoline ditosylate salt compounds
February 2008 - Glaxosmithkline Corporate Intellectual Property, Mai B475 patents
20080051395 - 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors
20080041368 - Medicament dispenser
20080042823 - Sensor system with acoustic transducer
20080045505 - 1-benzoyl substituted diazepine derivatives as selective histamine h3 receptor agonists
20080045506 - Pyrrolidine derivatives as histamine receptors ligands
20080045537 - Chemical compounds
20080035218 - Novel device
20080039444 - Compounds
20080029087 - Aerosol canister employing a polymeric film having improved moisture barrier properties
January 2008 - Glaxosmithkline Corporate Intellectual Property, Mai B475 patents
20080017193 - Medicament dispenser
20080021030 - Substituted pyrazoles as ppar agonists
20080021041 - Chemical compounds
20080021231 - Novel compounds
20080015360 - Novel compounds
20080008754 - Pharmaceutical compositions comprising (+)-(2s,3s)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol
20080009019 - High throughput method for screening candidate compounds for biological activity
20080009479 - Tetrahydrobenzazepines as histamine h3 receptor ligands
20080009541 - Novel receptor antagonists and their methods of use
20080003290 - Phenethanolamine derivatives for treatment of respiratory diseases
20080004294 - Heterocyclic compounds
20080004295 - Novel compounds
December 2007 - Glaxosmithkline Corporate Intellectual Property, Mai B475 patents
20070297989 - Novel anti-inflammatory androstane derivatives
20070299056 - Benzazepine derivatives for the treatment of neurological disorders
20070292513 - Chemical compounds
20070293489 - Substituted pyrazolopyrimidines
20070286851 - Method of identifying modulators of nogo-functions
20070287721 - Pyrazolopyridinyl pyridine
20070281971 - Novel compound
November 2007 - Glaxosmithkline Corporate Intellectual Property, Mai B475 patents
20070276000 - Chemical compounds
20070269427 - Therapeutical use of anti-myelin associated glycoprotein (mag) antibodies
20070270356 - Substituted 9a-n-[n'-(benzenesulfonyl)carbamoyl-y-aminopropyl] and 9a-n-[n'(b-cyanoethyl)-n'-(benzenesulfonyl)carbamoyl-y-aminopropyl]derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerithomycin a
20070270411 - Novel diazepine compounds as ligands of the melanocortin 1 and/or 4 receptors
20070270427 - Chemical compounds
20070270428 - Use of cyclooxygenase-2 inhibitors for the treatment of depressive disorders
20070270437 - Benzimidazole thiophene compounds
20070270475 - 4-methoxy-pyrrolidine-2-carboxylic acid compounds and derivatives thereof as hepatitis c virus inhibitors
20070261980 - Package
20070265187 - Oral formulations comprising bone morphogenetic proteins for treating metabolic bone diseases
20070265326 - Novel compounds
20070257202 - Luminescence sensor apparatus and method
20070259877 - Piperazine derivatives useful for the treatment of gastrointestinal disorders
20070251596 - Blending system and method
20070254910 - Chemical compounds
October 2007 - Glaxosmithkline Corporate Intellectual Property, Mai B475 patents
20070249600 - Chemical compounds
20070249630 - Phenethanolamine derivatives for treatment of respiratory diseases
20070249670 - Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof
20070249679 - Imidazol-2-one compounds useful in the treatment of various disorders
20070249705 - N-(1-(2,3-dihydro-1h-inden-5yl)-2-oxo-3-pyrrolidinyl)-sulfonamide derivatives for use as factor xa inhibitors
20070243196 - Mage-3 and ny-eso-1 based polyvalent vaccine for cancer immunotherapy
20070238737 - Novel compounds
20070238756 - Combinations of dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
20070238875 - Heterocyclic compounds
20070228065 - Dispenser
20070232590 - 3-cylcoalkylbenzazepines as histamine h3 antagonists
20070232615 - Chemical compounds
20070232623 - Pyrazolopyrimidine and pyrazolotriazine derivatives and pharmaceutical compositions containing them
20070232657 - Novel compounds
September 2007 - Glaxosmithkline Corporate Intellectual Property, Mai B475 patents
20070224130 - Tetrahydro-naphthalene derivatives as glucocorticoid receptor modulators
20070225294 - Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors
20070225340 - Phenyl compounds and their use in the treatment of conditions mediated by the action of pge2 at the ep1 receptor
20070225587 - Method for predicting deposition of inhaled medicament at the lung
20070219229 - Pyrrolopyridine derivatives
20070219247 - Medicament
20070219348 - Mutations in the mineralocorticoid receptor ligand binding domain polypeptide that permit structural determination of low affinity ligand complexes and screening methods employing same
20070209331 - Medicament housing apparatus having outer and inner containers
20070212692 - Generation of recombinant genes in prokaryotic cells by using two extrachromosomal elements
20070212758 - Methods for the production of 3-o-deactivated-4'-monophosphoryl lipid a (3d-mla)
20070213348 - Chemical compounds
20070208005 - Tetrahydrobenzazepines as antagonists and/or reverse agonists of the histamine h3 receptor
20070208023 - Cancer treatment method
August 2007 - Glaxosmithkline Corporate Intellectual Property, Mai B475 patents
20070202179 - Low dose pharmaceutical products
20070203180 - Substituted quinoline compounds for use as selective estrogen receptor modulator
20070203206 - 2-pyrrolidone derivatives and use thereof as factor xa inhibitors
20070203218 - Compounds which potentiate glutamate receptor and uses thereof in medicine
20070190583 - Predicitive biomarkers in cancer therapy
20070191426 - Derivatives of 3-aminocarbonylquinoline, pharmaceutical compositions containing them and processes and intermediates for their preparation
20070191479 - Aniline derivatives as selective androgen receptor modulators
20070184109 - Compositions comprising triptans and nsaids
20070184520 - Reduction of spontaneous mutation rates in cells
20070185089 - Benzazepine derivatives for the treatment of neurological and psychiatric disorders
20070175917 - Fluid dispenser
July 2007 - Glaxosmithkline Corporate Intellectual Property, Mai B475 patents
20070172385 - Benzothiophen and thiochrone containing phenethanolamine derivatives for the treatment of respiratory disorders
20070173499 - Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
20070163582 - Hand-held capsule device
20070163583 - Medicament dispenser
20070164049 - Fluid dispenser
20070166811 - Deracemisation of amines
20070167507 - 4-carbox pyrazole derivatives useful as anti-viral agents
20070167628 - Thiazole-2-carboxamide derivatives for use as hippar agonists in the treatment of i.a. dyslipidemia
20070168135 - Biological data set comparison method
20070161653 - Pyrazolo-pyridine derivatives as antiherpes agents
20070161665 - Cancer treatment method
20070161684 - 3-aminocarbonyl, 6-phenyl substituted pyridine-1-oxides as p38 kinase inhibitors
20070162250 - Object detection system, method and tool
20070155745 - Pyrrolidine derivatives as factor xa inhibitors
20070155805 - Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular disease
20070155839 - Cycloalkylidene compounds as modulators of estrogen receptor
June 2007 - Glaxosmithkline Corporate Intellectual Property, Mai B475 patents
20070145065 - Hand-held dispenser for dispensing unit products
20070148261 - Cancer treatment method
20070148641 - Method of screening for drug hypersensitivity reaction
20070149519 - Benzimidazol substituted thiopene derivatives with activity on ikk3
20070137643 - Fluid dispenser
20070138195 - Dispenser
20070138207 - Fluid dispensing device
20070139442 - Coated blending system
20070142365 - Naphthyridine integrase inhibitors
20070142373 - Quinoline derivatives as phosphodiesterase inhibitors
20070142374 - Pyrrolidine derivatives as factor xa inhibitors
20070142375 - Pyrrolidine derivatives as factor xa inhibitors
20070142378 - Method of treating restless legs syndrome and/or periodic limb movement disorder with (2s,3s) 2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol
20070142411 - Use of cyclooxygenase-2 selective inhibitors for the treatment of schizophrenic disorders
20070142437 - Chemical compounds
20070131225 - Hand-held capsule device
20070131717 - Fluid dispensing device
20070134268 - Vaccines
20070135414 - Tachykinin antagonists
20070135451 - Imidazo[1,2-a]pyridine derivatives for treatment of herpes viral infections
20070135490 - Phenetanolamine derivatives
20070125799 - Fluid dispenser
20070129367 - Pyridine derivatives as cb2 receptor modulators
May 2007 - Glaxosmithkline Corporate Intellectual Property, Mai B475 patents
20070122351 - Inhalation drug combinations
20070122352 - Inhalation drug combinations
20070123533 - New process for preparing an optically pure 2-morpholinol derivative
20070124152 - Hiv integrase inhibitors
20070116598 - Microfluidic system
20070107724 - Inhalation device
20070110803 - Pharmaceutical formulation comprising levothyroxine sodium
20070111971 - Novel compounds
20070112014 - Therapeutic compounds based on pyrazolopyridine
20070112114 - Pharmaceutical metered dose inhaler and methods relating thereto
20070105838 - Bicyclic benzamide compoundssa as histamine h3 receptor ligand useful in the treatment of neurological diseases
20070095851 - Dispenser
20070095853 - Metering pump system
20070099914 - Piperidine derivatives
20070099944 - Chemical compounds
20070099991 - Selective rxr ligands
April 2007 - Glaxosmithkline Corporate Intellectual Property, Mai B475 patents
20070091308 - System for real-time fluorescent determination of trace elements
20070093486 - Enzyme-catalyzed dynamic kinetic resolution process for preparing (+)-(2s,3s)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinoland salts and solvates thereof
20070093511 - Anhydrous crystal form of valaciclovir hydrochloride
20070093512 - Heterocyclic compounds
20070086878 - Object holding tool and object supporting unit for objects of different kind
20070088031 - Novel chemical compounds
20070088068 - Benzo[f]isoindole derivatives with affinity to the ep4 receptor
20070082912 - Pyrrole compounds for the treatment of prostaglandine mediated diseases
20070082919 - Process for preparing a co-precipitate of a non-crystalline solid drug substance
20070075141 - Sample container with radiofrequency identifier tag
20070078106 - Uracil reductase inactivators
20070078125 - Arylamine mch r1 antagonists
March 2007 - Glaxosmithkline Corporate Intellectual Property, Mai B475 patents
20070049570 - Quinoline derivatives as phosphodiesterase inhibitors
February 2007 - Glaxosmithkline Corporate Intellectual Property, Mai B475 patents
20070041899 - Radiolabelled substrates
20070043007 - Specific glucocorticosteroid compounds having anti-inflammatory activity
20070032535 - Diastereomeric dynamic kinetic resolution process for preparing (+)-(2s,3s)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol, salts, and solvates thereof
20070023038 - Drug dispensing components
20070027128 - Novel anti-inflammatory androstane derivative
20070027316 - Process for the preparation of (1s, 4r)-cis-4-'2-amino-6chloro-9h-purin-yl!-2-cyclopentene-1- methanol
January 2007 - Glaxosmithkline Corporate Intellectual Property, Mai B475 patents
20070015756 - Chemical compounds
20070015775 - Heterocyclic compounds
20070015796 - Compositions and methods for treatment of fibrosis
20070010540 - Crystal structure of liganded cfms kinase domain
20070010668 - Pyrimidine compounds
20070003976 - Car ligand-binding domain polypeptide co-crystallized with a ligand, and methods of designing ligands that modulate car activity
20070004724 - (+)-(2s,3s)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinor for treating anxiety
20070004807 - Methods using phenethanolamine derivatives for treatment of respiratory diseases
December 2006 - Glaxosmithkline Corporate Intellectual Property, Mai B475 patents
20060289008 - Dispenser with doses' counter
20060293298 - Compounds
20060293344 - Therapeutic compounds
20060293354 - Pyrimidine derivatives and their use as cb2 modulators
20060287286 - Phenethanolamine derivatives for treatment of respiratory diseases
20060287321 - Novel lactam derivatives
20060287325 - Combinations of paroxetine and 2-(r)-(4-fluoro-2-methyl-phenyl)-4-(s)-((8as)-6-oxo-hexahydro-pyrrolo'1,2-a!-pyrazin-2-yl)-piperidine-1-carboxylicacid'1-(r)-(3,5-bis-trifluoromethyl-phenyl)-
20060287389 - Phenethanolamine derivatives for treatment of respiratory diseases
20060281804 - Novel cycloalkyl'b! condensed indoles
20060276519 - Thiazole derivatives for treating ppar related disorders
November 2006 - Glaxosmithkline Corporate Intellectual Property, Mai B475 patents
20060270880 - 7-azaindole derivatives as cox2 inhibitors
20060257325 - Method and package for storing a pressurized container containing a drug
20060257978 - Deracemisation of amines
20060258720 - 1-acyl-pyrrolidine derivatives for the treatment of viral infections
20060258725 - Farnesoid x receptor agonists
20060249419 - Container for medicament powder
20060252943 - Chemical process
20060247219 - Specific glucocorticosteriod compound having anti-inflamatory activity
20060247227 - Substituted piperidines as histamine h3 receptor ligands
20060247261 - Pyrimidine compounds
October 2006 - Glaxosmithkline Corporate Intellectual Property, Mai B475 patents
20060237002 - Medicament dispenser
20060239932 - Pharmaceutical formulations comprising magnesium stearate
20060240048 - Pyridine derivatives as cb2 receptor modulators
20060240559 - 5-hydroxytryptamine transporter gene polymorphisms
20060241124 - Combinations comprising paroxetine and 2- (s) - (4-fluoro-2-methyl-phenyl) -piperazine-1-carboxylic acid [1- (r)- (3,5-bis-trifluoro-2-methyl-phenyl) -ethyl]-methyl amide for treatment of depression and/or anxiety
20060241143 - Combination of paroxetine and 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2s-phenyl-piperidin-3s-yl)-amine for treatment of depression and/or anxiety
20060233674 - Microfluidic apparatus having a vaporizer and method of using same
20060233716 - Pharmaceutical formulations
20060235043 - Antiviral pyrazolopyridine compounds
20060235057 - Phenyl compounds
20060229302 - Tricyclic indole derivatives and their use in the treatment of alzheimer's disease
20060229336 - Ccr5 antagonists as therapeutic agents
20060219813 - Nozzel for a nasal inhaler
20060223112 - Novel receptor
20060223800 - Pyrazolopyridines and pyrazolopyridazines adn antidiabetics
September 2006 - Glaxosmithkline Corporate Intellectual Property, Mai B475 patents
20060209628 - Energy delivery system
20060210481 - Medicament dispenser
20060210485 - Pharmaceutical formulations
20060211073 - Assay for b-raf activity based on intrinsic mek atpase activity
20060211589 - Pharmaceutical metered dose inhaler and methods relating thereto
20060211740 - Novel compounds
20060204966 - Treatment of cancers expressing p95 erbb2
20060205675 - Combinations of dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
20060205740 - Chemical compounds
20060205774 - 4-(4-(heterocyclylakoxy) phenyl-1-(heterocyclyl-carbonyl) piperidine derivavites and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer's
20060205790 - Medicinal arylethanolamine compounds
20060205794 - Phenethanolamine derivative for the treatment of respiratory diseases
20060196504 - Medicament dispenser
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Glaxosmithkline Corporate Intellectual Property, Mai B475 in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Glaxosmithkline Corporate Intellectual Property, Mai B475 with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support
|
REGISTER now for FREE 
